adamantane has been researched along with bromodeoxyuridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barone, G; Cusano, G; D'Incalci, M; Di Francesco, AM; Meco, D; Pierri, F; Pisano, C; Riccardi, R; Torella, AR; Ubezio, P | 1 |
Kadowaki, T; Kubota, N; Muraoka, T; Nakamura, A; Orime, K; Sato, K; Shinoda, K; Shirakawa, J; Terauchi, Y; Togashi, Y | 1 |
2 other study(ies) available for adamantane and bromodeoxyuridine
Article | Year |
---|---|
Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models.
Topics: Adamantane; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cinnamates; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Models, Biological; Neuroblastoma; Propidium; Receptors, Death Domain; Tretinoin | 2012 |
Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
Topics: Adamantane; Animal Feed; Animals; Apoptosis; Bromodeoxyuridine; Dipeptidyl-Peptidase IV Inhibitors; Glucose; Glucose Tolerance Test; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitriles; Pyrrolidines; Time Factors; Vildagliptin | 2012 |